DRIO - DarioHealth Corp.
| Previous Close | 9.19 |
| Open | 8.50 |
| Bid | 4.11 x 2200 |
| Ask | 0.00 x 1300 |
| Day's Range | 8.35 - 8.81 |
| 52 Week Range | 0.20 - 11.25 |
| Volume | 13,154 |
| Avg. Volume | 149,581 |
| Market Cap | 19.674M |
| Beta (5Y Monthly) | 0.24 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -8.16 |
| Earnings Date | Oct 27, 2019 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 11.00 |
- PR Newswire
DarioHealth Digital Diabetes Management System is Now Available at Albertsons
DarioHealth Corp. (NASDAQ: DRIO), a pioneer in the global digital therapeutics market, announced today the launch of its digital therapeutics solution for managing chronic diseases such as diabetes and hypertension on Albertsons Marketplace.
- PR Newswire
DarioHealth® Presents New Clinical Study Outcomes Showing the Dario Digital Therapeutics Platform Helps Insulin Dependent Patients With Diabetes Better Manage Their Chronic Condition
DarioHealth Corp. (Nasdaq: DRIO) ("DarioHealth" or "Dario"), a pioneer in the global digital therapeutics market, today presented a new clinical study at the Advanced Technologies & Treatments for Diabetes ("ATTD") conference in Madrid, Spain, which showed significant reductions of both hypoglycemic and high glycemic events in people with type 1 and insulin dependent type 2 diabetes using Dario's digital therapeutics platform. The presentation will be available at the conference, on the ATTD 2020 website during the conference, and online for one year following the conference. The accepted abstract will be published in the peer-reviewed journal Diabetes Technology & Therapeutics.
- PR Newswire
DarioHealth Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
DarioHealth Corp. (Nasdaq: DRIO) ("DarioHealth" or the "Company"), a pioneer in the global digital therapeutics market, announced today that on January 30, 2020, Richard Anderson was granted a non-qualified stock option award to purchase 90,000 shares of the Company's common stock, as well as an additional non-qualified performance-based stock option award to purchase an additional 90,000 shares of the Company's common stock, pursuant to Nasdaq Listing Rule 5635(c)(4) outside of the Company's existing equity compensation plans in connection with Mr. Anderson's previously-announced employment by the Company as its President and General Manager of North America. These options were granted as an inducement material to Mr. Anderson becoming an employee of the Company, in accordance with Nasdaq Listing Rule 5635(c)(4).
- PR Newswire
DarioHealth Strengthens Management Team With Appointment of Digital Health Veteran Rick Anderson as President and General Manager, North America
DarioHealth Corp. (Nasdaq: DRIO) ("DarioHealth" or the "Company"), a pioneer in the global digital therapeutics market, announced today the appointment of Richard Anderson as its President and General Manager of North America, effective January 13, 2020. Reporting to Chief Executive Officer Erez Raphael, Mr. Anderson will be responsible for both operational and commercial development, focusing primarily on the U.S. market. His appointment marks a key inflection point, supporting DarioHealth's strategic initiatives in the business-to-business (B2B) channel. This is one of many organizational changes that emphasize our focus on this large market. In conjunction with Mr. Anderson's appointment, DarioHealth will transition Olivier Jarry to serve as Senior Vice President of Strategy and Business Development.
- PR Newswire
DarioHealth Announces Closing of $21.3 Million Private Placement
DarioHealth Corp. (Nasdaq: DRIO) ("DarioHealth" or the "Company"), a pioneer in the global digital therapeutics market, announced today that it has closed on a private placement of convertible preferred stock to institutional and private investors. The Company received aggregate gross proceeds of approximately $21.3 million, before deducting placement agent fees and other offering expenses payable by the Company.
- Benzinga
A New Small Account Challnege: Higher By 50% In The First Week
Monday ended up being a non-starter thanks to a snowstorm that kept me from my regular trading station at Warrior Trading HQ. Despite that, Tuesday ended up being a stellar day that boosted my account by 40% thanks to one really strong position in DarioHealth Corp. (NASDAQ: DRIO). DRIO was the second leading stock on my morning gap scanner that day, up about 80%.
- Benzinga
DarioHealth Rips Higher On Walmart Distribution Deal
Shares of digital health company DarioHealth Corp (NASDAQ: DRIO ) are advancing strongly Tuesday. DarioHealth said its Dario-powered digital diabetes app has been launched on Walmart Inc's (NYSE: WMT ) ...
- MarketWatch
DarioHealth's shares jump on Walmart partnership news
Shares of DarioHealth Corp. jumped 103% as it announced that Walmart would sell DarioHealth's digital diabetes management system online. The company has established online partnerships with other retailers like Best Buy and Giant Eagle, a privately owned grocery chain. "In addition to Best Buy, we expect to announce our products in several of the top five retailers in the U.S." DarioHealth president and chief commercial officer Olivier Jarry told investors in October, according to a FactSet transcript of the third-quarter earnings call. "These retailers have told us that launching online is a natural stepping stone for them before planning to launch in their brick-and-mortar stores." DarioHealth's stock has fallen 67% year-to-date. The S&P 500 has gone up 24% during the same time period.
- PR Newswire
Walmart Starts Distributing the DarioHealth Digital Diabetes Management System
Global digital therapeutics innovation leader, DarioHealth Corp. (NASDAQ: DRIO) announced today the launch of the Dario-powered digital diabetes program on Walmart.com.
- PR Newswire
DarioHealth® Introduces "Membership-in-a-Box" to Brick and Mortar Retailers
Global digital therapeutics innovation leader, DarioHealth Corp. (NASDAQ: DRIO) ("DarioHealth" or "Dario"), announced today that its online membership offering will now be available for purchase in physical retail stores. The "Membership-in-a-Box" (MIB) package was designed to reach consumers with chronic conditions such as diabetes who shop at retail stores. This concept, started in partnership with Best Buy Online in the U.S., is now planned to expand to other retail chains. Prior to this expansion, retail stores only sold the Dario blood glucose meters, strips and other supplies. This is another move by Dario with the goal and potential to generate recurring revenues consistent with its high-margin, software as a service (SAAS) based model.
- PR Newswire
DarioHealth® Clinical Study Data Highlights the Material Benefit Digital Interventions Have on Glycemic Control in Users with Diabetes
- Based on data collected from active users, Dario proves digital interventions can play a key role in management of chronic conditions like diabetes - 45% of the study group reduced their average blood ...
- PR Newswire
DarioHealth Corp. CEO Erez Raphael Invited to Participate in BTIG Digital Health 2019
- DarioHealth CEO Joins Digital Health Industry Innovators panel in discussion on the need for clinical evidence CAESAREA, Israel and NEW YORK , Nov. 14, 2019 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: ...
- PR Newswire
Action Urgent Care Selects MyDario
SAN JOSE, California and NEW YORK, Nov. 12, 2019 /PRNewswire/ -- Global digital therapeutics innovation leader, DarioHealth Corp. (DRIO) announced today the launch of a Dario-powered digital diabetes program with Action Urgent Care. Action Urgent Care has experienced rapid growth since its first clinic opened in San Jose in 2013, to more than 40 points of care they operate throughout California today. The clinics offer a broad range of services including walk-ins for immediate care, primary care, specialized medicine, physical exams, diagnostics, preventative screenings and immunizations.
- Simply Wall St.
Should You Worry About DarioHealth Corp.'s (NASDAQ:DRIO) CEO Salary Level?
Erez Raphael has been the CEO of DarioHealth Corp. (NASDAQ:DRIO) since 2013. First, this article will compare CEO...
- Thomson Reuters StreetEvents
Edited Transcript of DRIO earnings conference call or presentation 28-Oct-19 1:00pm GMT
Q3 2019 DarioHealth Corp Earnings Call
- ACCESSWIRE
DarioHealth Corp. to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / October 28, 2019 / DarioHealth Corp. (NASDAQ: DRIO ) will be discussing their earnings results in their 2019 Third Quarter Earnings to be held on October 28, 2019 at 9:00 AM ...
- PR Newswire
DarioHealth Reports Results for Third Quarter 2019
NEW YORK and CAESAREA, Israel , Oct. 28, 2019 /PRNewswire/ -- Global digital therapeutics innovator DarioHealth Corp. (Nasdaq: DRIO), today reported financial and operational results for the third quarter ...
- PR Newswire
DarioHealth Appoints Digital Therapeutics Pioneer Dr. Abigail Hirsch to Its Advisory Board to Support Commercial Strategy and Execution
CAESAREA, Israel and NEW YORK, Oct. 22, 2019 /PRNewswire/ -- DarioHealth Corp. (DRIO) ("DarioHealth" or "Dario"), a leading, global digital therapeutics company, has appointed Dr. Abigail Hirsch to its Advisory Board where she will help guide commercial and Business-to-Business (B2B) efforts. Dr. Hirsch has many years of experience utilizing clinical psychology, data analytics and educational design to create innovative healthcare technology that helps people lead healthier, more fulfilling lives. Prior to joining Dario, Dr. Hirsch served as Chief Clinical Officer at a behavioral health company called myStrength, helping lead the company from inception through its acquisition by Livongo Health, Inc. in the first quarter of 2019.
- PR Newswire
DarioHealth to Host Third Quarter 2019 Conference Call October 28, 2019
Earnings Discussion and Business Update Scheduled for 9:00 am EDT NEW YORK and CAESAREA, Israel , Oct. 17, 2019 /PRNewswire/ -- Global digital therapeutics innovation leader DarioHealth Corp. (NASDAQ: ...
- PR Newswire
DarioHealth CEO Erez Raphael Presents to Digital Therapeutics Leaders at DTx East 2019
NEW YORK and CAESAREA, Israel, Sept. 23, 2019 /PRNewswire/ -- DarioHealth Corp. (DRIO) ("DarioHealth" or "Dario"), a leading, global digital therapeutics company, today announced that Erez Raphael, DarioHealth's Chief Executive Officer, will be a speaker at the second annual DTx East 2019 conference taking place at Harvard Medical School in Boston, MA from September 24-26, 2019. DTx East provides a forum for key decision makers and innovators in the rapidly expanding digital therapeutics industry to network, learn and share ideas. The three-day conference provides a meeting point for more than 300 senior leaders from a range of digital therapeutic companies, including pharmaceutical companies, investors, payers and health care providers.
- Simply Wall St.
Does DarioHealth Corp. (NASDAQ:DRIO) Need To Raise More Cash?
DarioHealth Corp. (NASDAQ:DRIO) continues its loss-making streak, announcing negative earnings for its latest...
- PR Newswire
DarioHealth Awarded U.S. Patent for Optical Transmission of Data Between a Sensor and Smart Device
NEW YORK and CAESAREA, Israel, Sept. 18, 2019 /PRNewswire/ -- DarioHealth Corp. ("DarioHealth" or "Dario") (DRIO), a leading, global digital therapeutics company, today announced that it has received a notice of allowance from the U.S. Patent and Trademark Office titled "Systems and Methods for Enabling Optical Transmission of Data Between a Sensor and a Smart Device." The patent will allow Dario to develop paired smartphone devices that can collect and analyze real-time medical data and provide immediate and highly detailed, personalized data reports to the user. Once collected, this data can be shared with healthcare providers through the DarioEngage™ platform to facilitate digital health interventions based on the data analysis. "Dario's business and product strategy is guided by evidence that shows that increased user engagement and direct empowerment of individuals to manage their personal health leads to better medical outcomes," said Erez Raphael, DarioHealth's chief executive officer.
- PR Newswire
Dance Biopharm Partners With DarioHealth to Expand Access to Digital Therapeutics Platform for Patients With Chronic Diseases
DURHAM, North Carolina and NEW YORK, Sept. 11, 2019 /PRNewswire/ -- Dance Biopharm Holdings, Inc., a clinical-stage company reimagining the treatment of chronic diseases with inhaled therapies, announced today it has formed a strategic alliance with DarioHealth Corp. "Dario" (DRIO), a leading, global digital therapeutics company, to expand access to a personalized digital health management platform for patients with chronic diseases. Under the terms of the agreement, Dance Biopharm will integrate its gentle mist smart inhaler into DarioHealth's digital therapeutics platform to provide patients automated, real-time treatment data through an advanced mobile application.
- PR Newswire
DarioHealth to Present at RHK Capital Disruptive Growth Conference on Thursday, September 5th
NEW YORK and CAESAREA, Israel , Aug. 28, 2019 /PRNewswire/ -- Leading global digital therapeutics company DarioHealth Corp. (Nasdaq: DRIO) today announced that DarioHealth's Chief Executive Officer, Erez ...
- Thomson Reuters StreetEvents
Edited Transcript of DRIO earnings conference call or presentation 13-Aug-19 1:00pm GMT
Q2 2019 DarioHealth Corp Earnings Call
